Crucible · Firm report card

Aliva Biopharmaceuticals

CA · SBIR awardee across 2 federal programs (NSF, HHS/NIH), first award 2005.

2SBIR awards
$229,030SBIR $
2 → 0Phase I → II
$0Follow-on federal $
0Follow-on contracts

SBIR awards by program

ProgramAwardsSBIR $Phase IPhase II
NSF 1 $100,000 1 0
HHS/NIH 1 $129,030 1 0

Mission areas

Open the interactive profile of Aliva Biopharmaceuticals →

Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.

Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Methodology